Jingjing Zhang
Jingjing Zhang has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Junjie Bi
Department of Gerontology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China
4 shared publications Xue Liu
Department of Respiratory Medicine Affiliated Hospital of Shandong University of Traditional Chinese Medicine Jinan China
3 shared publicationsLiqun Zhao
Geriatric Medicine Center, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China
2 shared publications- Liqun Zhao
Geriatric Medicine Center Affiliated Hospital of Shandong University of Traditional Chinese Medicine Jinan China
2 shared publications Xiaoming Liu
Geriatric Medicine Center Affiliated Hospital of Shandong University of Traditional Chinese Medicine Jinan China
2 shared publicationsWei Zhang
Department of Respiratory Medicine, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China
1 shared publication
Latest Publications
- Open Access
- 15 March 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (3) , e70840
Cell‐Type‐Specific WTAP and ALKBH5 ‐Mediated m 6 A Methylation Orchestrates Mental Disorders via Gut‐Brain Axis Metabolite Signaling: Multi‐Omics Evidence and Pyroptosis‐Associated Loop Mechanism
Introduction: Mental disorders affect one billion people and contribute 5% of global DALYs. Although N6‐methyladenosine (m 6 A) modification, gut microbiota, cerebrospinal fluid (CSF) metabolites, and pyroptosis have been implicated in disease pathogenesis, the directionality and magnitude of causal links remain elusive. We integrated two‐sample Mendelian randomization (MR) with single‐cell eQTL data to generate hypotheses regarding these relationships. Methods: Using large‐scale GWAS summary statistics, we estimated the causal effects of m 6 A regulators, gut microbiota, CSF metabolites, and pyroptosis on depression, schizophrenia (SZ), bipolar disorder (BD), attention‐deficit/hyperactivity disorder (ADHD), and post‐traumatic stress disorder (PTSD). Mediation analysis quantified hypothesized microbiota‐ and metabolite‐mediated proportions; single‐cell eQTL from 14 immune subsets localized genetic associations to cell types. Results: MR analysis suggested distinct causal associations of m 6 A modifiers (WTAP/ALKBH5) with mental disorders. Gut microbiota (e.g., GCA‐900066755, Bacillus) and CSF metabolites (e.g., theophylline, isoleucine) were estimated to potentially mediate 5.06%–45.28% of these effects, forming pathways such as WTAP → GCA‐900066755 → theophylline → ADHD and ALKBH5 → CAG‐390 → isoleucine → PTSD. These represent statistically inferred associations rather than experimentally validated pathways. Notably, these proportions were not based on multiple‐testing–corrected associations. Single‐cell eQTL mapping associated WTAP's ADHD risk with XCL1‐NK cells (OR = 1.445). Bidirectional MR suggested potential reciprocal associations between mental disorders and microbial/metabolite profiles. Pyroptosis demonstrated a tentative statistical association (3.99% explanatory power), though its specific biological role remains undefined. Conclusion: This multi‐omics integration generates a hypothesis regarding a potential m 6 A–microbiota–metabolite axis that may be associated with mental disorders, with pyroptosis as a potentially related peripheral factor. Should these associations prove causal, the identified relationships could suggest peripheral intervention nodes, while combinatorial targeting might provide directions for preventive psychiatry. Experimental validation is required to confirm the biological mechanisms implied by these genetic associations.
- 15 March 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (3) , e70840
Open AccessCell‐Type‐Specific WTAP and ALKBH5 ‐Mediated m 6 A Methylation Orchestrates Mental Disorders via Gut‐Brain Axis Metabolite Signaling: Multi‐Omics Evidence and Pyroptosis‐Associated Loop Mechanism
Introduction: Mental disorders affect one billion people and contribute 5% of global DALYs. Although N6‐methyladenosine (m 6 A) modification, gut microbiota, cerebrospinal fluid (CSF) metabolites, and pyroptosis have been implicated in disease pathogenesis, the directionality and magnitude of causal links remain elusive. We integrated two‐sample Mendelian randomization (MR) with single‐cell eQTL data to generate hypotheses regarding these relationships. Methods: Using large‐scale GWAS summary statistics, we estimated the causal effects of m 6 A regulators, gut microbiota, CSF metabolites, and pyroptosis on depression, schizophrenia (SZ), bipolar disorder (BD), attention‐deficit/hyperactivity disorder (ADHD), and post‐traumatic stress disorder (PTSD). Mediation analysis quantified hypothesized microbiota‐ and metabolite‐mediated proportions; single‐cell eQTL from 14 immune subsets localized genetic associations to cell types. Results: MR analysis suggested distinct causal associations of m 6 A modifiers (WTAP/ALKBH5) with mental disorders. Gut microbiota (e.g., GCA‐900066755, Bacillus) and CSF metabolites (e.g., theophylline, isoleucine) were estimated to potentially mediate 5.06%–45.28% of these effects, forming pathways such as WTAP → GCA‐900066755 → theophylline → ADHD and ALKBH5 → CAG‐390 → isoleucine → PTSD. These represent statistically inferred associations rather than experimentally validated pathways. Notably, these proportions were not based on multiple‐testing–corrected associations. Single‐cell eQTL mapping associated WTAP's ADHD risk with XCL1‐NK cells (OR = 1.445). Bidirectional MR suggested potential reciprocal associations between mental disorders and microbial/metabolite profiles. Pyroptosis demonstrated a tentative statistical association (3.99% explanatory power), though its specific biological role remains undefined. Conclusion: This multi‐omics integration generates a hypothesis regarding a potential m 6 A–microbiota–metabolite axis that may be associated with mental disorders, with pyroptosis as a potentially related peripheral factor. Should these associations prove causal, the identified relationships could suggest peripheral intervention nodes, while combinatorial targeting might provide directions for preventive psychiatry. Experimental validation is required to confirm the biological mechanisms implied by these genetic associations.
- Open Access
- 20 January 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Host m6A modifications shape microbiota that drives cell specific ferroptosis as a causal pathway to chronic respiratory diseases
Globally, chronic respiratory diseases (CRDs) are leading causes of mortality, morbidity, and disability-adjusted life years (DALYs), imposing substantial economic and societal burdens. Uncovering the pathogenic mechanisms underlying CRDs is therefore crucial. While prior studies have implicated gut and skin microbiota in CRD development, the extent of their influence remains inconsistent. The exact causal links between these microbial communities and CRDs are yet to be fully elucidated, and the roles of N6-methyladenosine (m⁶A) modifications and ferroptosis in these links remain poorly understood. To investigate how gut and skin microbiota, m⁶A modifications, and ferroptosis collectively influence CRDs, we used summary-level data from genome-wide association studies (GWAS). We studied five CRDs: chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease (ILD), pneumoconiosis, and pulmonary arterial hypertension (PAH). Using Mendelian randomization (MR) methods, we examined causal relationships between these factors. Furthermore, we explored the potential mediating effects of microbiota in the m⁶A-CRDs pathway and of ferroptosis in the microbiota-CRDs pathway. To identify genes underlying these molecular layers, we confirmed significant differential expression of m⁶A and ferroptosis-related candidates between disease and control tissues, then applied immune single-cell eQTL data from 14 distinct cell types to dissect how these genes modulate disease risk in individual immune cells. Our comprehensive analysis showed associations between gut and skin microbiota and CRDs. Importantly, we identified that METTL14-mediated m⁶A modification influences ILD through the gut microbiota, and that NDRG1-mediated ferroptosis plays a significant role in the progression from gut microbiota dysbiosis to COPD. Both genes were differentially expressed between disease and control tissues, and single-cell eQTL mapping localized NDRG1 exclusively to Monocyte FCGR3A + cells. Our findings provide preliminary genetic evidence of potential causal links between gut and skin microbiota and CRDs, with m⁶A modifications and cell-type-specific ferroptosis contributing to regulatory mechanisms in these pathways.
- 20 January 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessHost m6A modifications shape microbiota that drives cell specific ferroptosis as a causal pathway to chronic respiratory diseases
Globally, chronic respiratory diseases (CRDs) are leading causes of mortality, morbidity, and disability-adjusted life years (DALYs), imposing substantial economic and societal burdens. Uncovering the pathogenic mechanisms underlying CRDs is therefore crucial. While prior studies have implicated gut and skin microbiota in CRD development, the extent of their influence remains inconsistent. The exact causal links between these microbial communities and CRDs are yet to be fully elucidated, and the roles of N6-methyladenosine (m⁶A) modifications and ferroptosis in these links remain poorly understood. To investigate how gut and skin microbiota, m⁶A modifications, and ferroptosis collectively influence CRDs, we used summary-level data from genome-wide association studies (GWAS). We studied five CRDs: chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease (ILD), pneumoconiosis, and pulmonary arterial hypertension (PAH). Using Mendelian randomization (MR) methods, we examined causal relationships between these factors. Furthermore, we explored the potential mediating effects of microbiota in the m⁶A-CRDs pathway and of ferroptosis in the microbiota-CRDs pathway. To identify genes underlying these molecular layers, we confirmed significant differential expression of m⁶A and ferroptosis-related candidates between disease and control tissues, then applied immune single-cell eQTL data from 14 distinct cell types to dissect how these genes modulate disease risk in individual immune cells. Our comprehensive analysis showed associations between gut and skin microbiota and CRDs. Importantly, we identified that METTL14-mediated m⁶A modification influences ILD through the gut microbiota, and that NDRG1-mediated ferroptosis plays a significant role in the progression from gut microbiota dysbiosis to COPD. Both genes were differentially expressed between disease and control tissues, and single-cell eQTL mapping localized NDRG1 exclusively to Monocyte FCGR3A + cells. Our findings provide preliminary genetic evidence of potential causal links between gut and skin microbiota and CRDs, with m⁶A modifications and cell-type-specific ferroptosis contributing to regulatory mechanisms in these pathways.
- Open Access
- 12 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (50) , e46718
Systematic druggable genome-wide mendelian randomization identifies therapeutic targets for childhood asthma
The management and prevention of childhood asthma remain significant challenges. Mendelian randomization (MR) has emerged as a valuable tool for identifying novel therapeutic targets. In response, we conducted a comprehensive, druggable genome-wide MR analysis to elucidate potential therapeutic targets for childhood asthma. Our study integrated genomic data concerning druggable targets, expression quantitative trait loci (eQTLs), and results from genome-wide association studies on childhood asthma. Employing the MR technique, we explored the putative causal links between genes that are targets for drugs and the development of childhood asthma. To validate these causal associations, we utilized reverse MR analyses along with colocalization techniques. Moreover, we performed enrichment analysis, mapped protein interaction networks, and executed drug prediction algorithms and molecular docking studies. These methodologies were applied to gain critical insights that could guide the development of more potent and precise therapeutic agents. We identified 35 druggable genes significantly associated with childhood asthma (including BLVRA, SLC9A3, LYZ, SRPK1, HOXA5, LYVE1, S100A9, ADORA1, RPL13, IL7R, SLFN11, SHMT1, CLN8, TOP1MT, LPAR5, RNASET2, ANK1, H6PD, DSP, CDC25B, VWF, ITK, CACNG6, ITGB7, S100A8, ADAM12, ST14, BMP6, HK2, SYK, ABCA1, ULK4, KBTBD2, SLCO4C1), with BLVRA showing promise as a target. Our research suggests that BLVRA may be a promising target for childhood asthma treatment, aiding in the prioritization of drug development for childhood asthma.
- 12 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (50) , e46718
Open AccessSystematic druggable genome-wide mendelian randomization identifies therapeutic targets for childhood asthma
The management and prevention of childhood asthma remain significant challenges. Mendelian randomization (MR) has emerged as a valuable tool for identifying novel therapeutic targets. In response, we conducted a comprehensive, druggable genome-wide MR analysis to elucidate potential therapeutic targets for childhood asthma. Our study integrated genomic data concerning druggable targets, expression quantitative trait loci (eQTLs), and results from genome-wide association studies on childhood asthma. Employing the MR technique, we explored the putative causal links between genes that are targets for drugs and the development of childhood asthma. To validate these causal associations, we utilized reverse MR analyses along with colocalization techniques. Moreover, we performed enrichment analysis, mapped protein interaction networks, and executed drug prediction algorithms and molecular docking studies. These methodologies were applied to gain critical insights that could guide the development of more potent and precise therapeutic agents. We identified 35 druggable genes significantly associated with childhood asthma (including BLVRA, SLC9A3, LYZ, SRPK1, HOXA5, LYVE1, S100A9, ADORA1, RPL13, IL7R, SLFN11, SHMT1, CLN8, TOP1MT, LPAR5, RNASET2, ANK1, H6PD, DSP, CDC25B, VWF, ITK, CACNG6, ITGB7, S100A8, ADAM12, ST14, BMP6, HK2, SYK, ABCA1, ULK4, KBTBD2, SLCO4C1), with BLVRA showing promise as a target. Our research suggests that BLVRA may be a promising target for childhood asthma treatment, aiding in the prioritization of drug development for childhood asthma.
- Open Access
- 6 August 2025
- Published by Springer Nature in BMC Medical Genomics
- Vol. 18 (1) , 1-16
Blood cell perturbation responses mediate the causal relationship between the gut microbiota and asthma: a bidirectional Mendelian randomization study
Asthma is a complex and heterogeneous disease presenting with a wide range of phenotypes. While prior studies have highlighted the importance of gut microbiota in asthma development, the extent of their influence varies. The exact causal links between gut microbiota and asthma remain to be fully understood, and the role of blood cell perturbation responses as potential mediators in this relationship remains unclear. To elucidate the connections between gut microbiota, blood cell perturbation responses, and asthma, we utilized data from comprehensive genome-wide association studies (GWAS). Our investigation covered six distinct asthma phenotypes: unspecified asthma, eosinophilic asthma, allergic asthma, childhood asthma, non-allergic asthma, and obesity-related asthma. Employing Mendelian randomization (MR) techniques, we evaluated the causal associations among gut microbiota, blood cell perturbation responses, and these asthma phenotypes, primarily using inverse variance weighting (IVW) for statistical analysis. Furthermore, we examined the potential mediating effects of blood cell perturbation responses on the relationship between gut microbiota and asthma. Our comprehensive analysis uncovered significant interactions among gut microbiota, blood cell perturbation responses, and asthma. We pinpointed five specific blood cell perturbation responses that play a crucial role in modulating the progression of three distinct asthma phenotypes. Our investigation yields compelling evidence of causal connections between gut microbiota and asthma, with blood cell perturbation responses serving as pivotal mediators in this pathway.
- 6 August 2025
- Published by Springer Nature in BMC Medical Genomics
- Vol. 18 (1) , 1-16
Open AccessBlood cell perturbation responses mediate the causal relationship between the gut microbiota and asthma: a bidirectional Mendelian randomization study
Asthma is a complex and heterogeneous disease presenting with a wide range of phenotypes. While prior studies have highlighted the importance of gut microbiota in asthma development, the extent of their influence varies. The exact causal links between gut microbiota and asthma remain to be fully understood, and the role of blood cell perturbation responses as potential mediators in this relationship remains unclear. To elucidate the connections between gut microbiota, blood cell perturbation responses, and asthma, we utilized data from comprehensive genome-wide association studies (GWAS). Our investigation covered six distinct asthma phenotypes: unspecified asthma, eosinophilic asthma, allergic asthma, childhood asthma, non-allergic asthma, and obesity-related asthma. Employing Mendelian randomization (MR) techniques, we evaluated the causal associations among gut microbiota, blood cell perturbation responses, and these asthma phenotypes, primarily using inverse variance weighting (IVW) for statistical analysis. Furthermore, we examined the potential mediating effects of blood cell perturbation responses on the relationship between gut microbiota and asthma. Our comprehensive analysis uncovered significant interactions among gut microbiota, blood cell perturbation responses, and asthma. We pinpointed five specific blood cell perturbation responses that play a crucial role in modulating the progression of three distinct asthma phenotypes. Our investigation yields compelling evidence of causal connections between gut microbiota and asthma, with blood cell perturbation responses serving as pivotal mediators in this pathway.